Endothelin, hypertension and chronic kidney disease: new insights
DE Kohan - Current opinion in nephrology and hypertension, 2010 - journals.lww.com
DE Kohan
Current opinion in nephrology and hypertension, 2010•journals.lww.comEndothelin is a promising target in the treatment of resistant hypertension and CKD, with
additional potential benefits on atherosclerosis and the metabolic syndrome. The nature and
mechanisms of drug side effects require elucidation before the potential of this new class of
drugs can be fully realized.
additional potential benefits on atherosclerosis and the metabolic syndrome. The nature and
mechanisms of drug side effects require elucidation before the potential of this new class of
drugs can be fully realized.
Summary
Endothelin is a promising target in the treatment of resistant hypertension and CKD, with additional potential benefits on atherosclerosis and the metabolic syndrome. The nature and mechanisms of drug side effects require elucidation before the potential of this new class of drugs can be fully realized.
Lippincott Williams & Wilkins